Parkinson's disease
OBJECTIVES: To assess the efficacy and safety of adjunct bromocriptine (BR)       compared with placebo in the treatment of patients with Parkinson's disease (PD)        who have motor complications.
OBJECTIVES: To assess the efficacy and safety of adjunct bromocriptine (BR)       compared with placebo in the treatment of  @OBJECT$   @PREDICAT$   @SUBJECT$  (PD)        who have motor complications.